DIA 2020 Virtual Global Annual Meeting has ended

Create Your Own Event

DIA 2020 Virtual Global Annual Meeting

arrow_back View All Dates

8:00am EDT

#401 L: Digital Risk Minimization: How Can We Advance Adoption? TBD #402 L: FDA Perspectives on Modernization of Clinical Trials: Real World Evidence, Decentralized Clinical Trials, and Digital Health Technologies TBD #404 L: Incorporating Patient Input into Medical Product Development and the US Food and Drug Administration’s Decision-Making TBD

9:30am EDT

#415 SL: Opportunities and Challenges for Real World Data and Real World Evidence: Dive Into the Details TBD

11:30am EDT

#422 L: How the FDA’s MyStudies Platform is Accelerating the Use of Digital Technology in Clinical Research and Clinical Trials TBD

5:00pm EDT

#504.1 OD: ON DEMAND - The Opioid Epidemic: Top Ten Lessons in Regulatory Science TBD #514 OD: ON DEMAND - Single-Sponsor Master Protocol: Development and Regulatory Experience with a Complex Innovative Design (CID) TBD #535 OD: ON DEMAND - Developing Products by the FDA Animal Rule: Working with FDA and Real World Challenges TBD #547 OD: ON DEMAND - New Drugs Regulatory Program Modernization TBD #550 OD: ON DEMAND - PMDA Town Hall: The Path of a New Chief Executive Since His Appointment TBD #551 OD: ON DEMAND - Advancing Clinical Trial Innovation Through Model-Informed Drug Development TBD #552 OD: ON DEMAND - Regulatory Barriers to Entry for Biosimilars TBD #554 OD: ON DEMAND - Strengthening Food and Drug Regulatory Systems Abroad: Recommendations from the FDA-Commissioned NASEM Report TBD #555 OD: ON DEMAND - Updates of Drug Evaluation and Inspection in China TBD #549 OD: ON DEMAND - Translating Frequently Collected Patient Experience Data into Meaningful Trial Endpoints TBD #556 OD: ON DEMAND - Demystifying Global Device Requirements: High Level Comparison of Current Expectations TBD